Julian Mackay‐Wiggan

3.6k total citations · 1 hit paper
26 papers, 2.0k citations indexed

About

Julian Mackay‐Wiggan is a scholar working on Pathology and Forensic Medicine, Urology and Molecular Biology. According to data from OpenAlex, Julian Mackay‐Wiggan has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 9 papers in Urology and 8 papers in Molecular Biology. Recurrent topics in Julian Mackay‐Wiggan's work include Hair Growth and Disorders (9 papers), Autoimmune Bullous Skin Diseases (6 papers) and Hedgehog Signaling Pathway Studies (5 papers). Julian Mackay‐Wiggan is often cited by papers focused on Hair Growth and Disorders (9 papers), Autoimmune Bullous Skin Diseases (6 papers) and Hedgehog Signaling Pathway Studies (5 papers). Julian Mackay‐Wiggan collaborates with scholars based in United States. Julian Mackay‐Wiggan's co-authors include Raphael Clynes, Angela M. Christiano, Ali Jabbari, Jane Cerise, Charlotte Clark, Lynn Petukhova, Jean Y. Tang, Anita M. Chanana, Joselyn Lindgren and Zhenpeng Dai and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Cancer Research.

In The Last Decade

Julian Mackay‐Wiggan

26 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition

2014 652 citations Luzhou Xing, Zhenpeng Dai et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julian Mackay‐Wiggan United States	14	917	853	641	475	377	26	2.0k
Johannes S. Kern Germany	24	236 0.3×	133 0.2×	430 0.7×	814 1.7×	184 0.5×	83	2.0k
Robert Dinser Germany	16	114 0.1×	73 0.1×	474 0.7×	317 0.7×	189 0.5×	32	1.7k
Denisa Kacerovská Czechia	24	1.0k 1.1×	50 0.1×	361 0.6×	343 0.7×	391 1.0×	106	1.8k
Leila Jeskanen Finland	21	213 0.2×	52 0.1×	248 0.4×	91 0.2×	140 0.4×	39	1.1k
Andreas R. Günthert Germany	24	59 0.1×	236 0.3×	346 0.5×	85 0.2×	167 0.4×	52	1.4k
Daniel C. Zedek United States	16	164 0.2×	60 0.1×	259 0.4×	114 0.2×	117 0.3×	41	762
Jason E. Cain Australia	26	57 0.1×	245 0.3×	1.3k 2.0×	108 0.2×	101 0.3×	66	2.0k
Fumiaki Shirasaki Japan	17	246 0.3×	24 0.0×	488 0.8×	263 0.6×	148 0.4×	24	1.2k
A L Kariniemi Finland	17	201 0.2×	44 0.1×	630 1.0×	74 0.2×	123 0.3×	29	1.6k
Hiromaro Kiryu Japan	15	389 0.4×	23 0.0×	332 0.5×	146 0.3×	190 0.5×	59	1.4k

Countries citing papers authored by Julian Mackay‐Wiggan

Since Specialization

Citations

This map shows the geographic impact of Julian Mackay‐Wiggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Mackay‐Wiggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Mackay‐Wiggan more than expected).

Fields of papers citing papers by Julian Mackay‐Wiggan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julian Mackay‐Wiggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Mackay‐Wiggan. The network helps show where Julian Mackay‐Wiggan may publish in the future.

Co-authorship network of co-authors of Julian Mackay‐Wiggan

This figure shows the co-authorship network connecting the top 25 collaborators of Julian Mackay‐Wiggan. A scholar is included among the top collaborators of Julian Mackay‐Wiggan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Mackay‐Wiggan. Julian Mackay‐Wiggan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kempers, Steven, Natasha Atanaskova Mesinkovska, Paradi Mirmirani, et al.. (2025). 62823 Optimization of deuruxolitinib dosing in adult patients with alopecia areata: Results from a randomized, parallel-group, multicenter, Phase 2 trial. Journal of the American Academy of Dermatology. 93(3). AB260–AB260. 2 indexed citations

Jong, Annemieke de, Ali Jabbari, Zhenpeng Dai, et al.. (2018). High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata. JCI Insight. 3(19). 45 indexed citations

Jabbari, Ali, et al.. (2018). 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata. Journal of Investigative Dermatology. 138(5). S77–S77. 1 indexed citations

Jabbari, Ali, Jane Cerise, James C. Chen, et al.. (2018). An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis. Journal of Investigative Dermatology. 138(7). 1539–1545. 135 indexed citations

Mackay‐Wiggan, Julian, et al.. (2017). 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata. Journal of Investigative Dermatology. 137(5). S54–S54. 1 indexed citations

Jabbari, Ali, et al.. (2017). 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata. Journal of Investigative Dermatology. 137(5). S56–S56. 2 indexed citations

Tang, Jean Y., Mina S. Ally, Anita M. Chanana, et al.. (2016). Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Oncology. 17(12). 1720–1731. 81 indexed citations

Jabbari, Ali, Jane Cerise, James C. Chen, et al.. (2016). Molecular signatures define alopecia areata subtypes and transcriptional biomarkers. EBioMedicine. 7. 240–247. 76 indexed citations

Mackay‐Wiggan, Julian, Ali Jabbari, Nhan Nguyen, et al.. (2016). Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. JCI Insight. 1(15). e89790–e89790. 213 indexed citations

10.

Tang, Jean Y., Albert S. Chiou, Julian Mackay‐Wiggan, et al.. (2014). Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome. Cancer Prevention Research. 7(3). 292–299. 25 indexed citations

11.

Clark, Charlotte, et al.. (2014). Basal Cell Carcinoma: An Evidence-Based Treatment Update. American Journal of Clinical Dermatology. 15(3). 197–216. 82 indexed citations

12.

Xing, Luzhou, Zhenpeng Dai, Ali Jabbari, et al.. (2014). Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nature Medicine. 20(9). 1043–1049. 652 indexed citations breakdown →

13.

Zhao, Wenjing, et al.. (2014). An Oral Phosphodiesterase Inhibitor (Apremilast) for Inflammatory Rosacea in Adults: A Pilot Study. JAMA Dermatology. 150(9). 1013–1013. 12 indexed citations

14.

Ally, Mina S., Jean Y. Tang, Joselyn Lindgren, et al.. (2014). The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome. JAMA Dermatology. 150(5). 542–542. 38 indexed citations

15.

Tang, Jean Y., Julian Mackay‐Wiggan, Michelle Aszterbaum, et al.. (2012). Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome. New England Journal of Medicine. 366(23). 2180–2188. 383 indexed citations

16.

Sherber, Noëlle, et al.. (2011). Efficacy and safety study of tazarotene cream 0.1% for the treatment of brittle nail syndrome.. PubMed. 87(2). 96–103. 9 indexed citations

17.

Petukhova, Lynn, Rita Cabral, Julian Mackay‐Wiggan, Raphael Clynes, & Angela M. Christiano. (2011). The genetics of alopecia areata: What's new and how will it help our patients?. Dermatologic Therapy. 24(3). 326–336. 37 indexed citations

18.

Wang, Shuang, et al.. (2010). Prospective study of wound infections in Mohs micrographic surgery using clean surgical technique in the absence of prophylactic antibiotics. Journal of the American Academy of Dermatology. 63(5). 842–851. 70 indexed citations

19.

Mackay‐Wiggan, Julian, David J. Cohen, Mark A. Hardy, Elizabeth Knobler, & Marc E. Grossman. (2003). Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). Journal of the American Academy of Dermatology. 48(1). 55–60. 127 indexed citations

20.

Mackay‐Wiggan, Julian, et al.. (2003). Onycholysis associated with paclitaxel.. PubMed. 71(3). 229–32. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact